CHD2 and epilepsy: A more recent approach conducted by LaFlamme et al. [67] in 2024 used a similar approach, but with different thresholds (≥99.25th or ≤0.75th percentile), and accounted for sex-specific X chromosome methylation patterns rather than excluding them altogether in pediatric epilepsies and patients with CHD2 variants.